CMRX

Chimerix, Inc.

1.20 USD
-0.00 (-0.41%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Chimerix, Inc. stock is up 31.87% since 30 days ago. The next earnings date is Feb 29, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 63.64% of the previous 10 February’s closed higher than January.

About Chimerix, Inc.

Chimerix, Inc. develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox.